NCT03508752View on ClinicalTrials.gov

Neurocognitive Decline in Patients With Brain Metastases

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 5, 2017

Primary Completion Date

February 26, 2026

Study Completion Date

February 26, 2026

Conditions
Brain Metastases
Interventions
RADIATION

Stereotactic Radiosurgery

Stereotactic Radiosurgery dose is based on the largest tumor size

Trial Locations (1)

75390

RECRUITING

University of Texas Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER